PRA Health Sciences is a contract research organization that provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic expertise in areas including pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its service offerings include both traditional, project‑based Phase I through Phase IV services as well as embedded and functional outsourcing services.

Type
Public
HQ
Raleigh, US
Founded
1976
Size (employees)
13,000 (est)
Website
prahs.com
PRA Health Sciences was founded in 1976 and is headquartered in Raleigh, US
Report incorrect company information

PRA Health Sciences Office Locations

PRA Health Sciences has an office in Raleigh
Raleigh, US (HQ)
400 4130 Parklake Ave
Show all (1)
Report incorrect company information

PRA Health Sciences Financials and Metrics

PRA Health Sciences Financials

PRA Health Sciences's revenue was reported to be $1.81 b in FY, 2016 which is a 12.3% increase from the previous period.
USD

Revenue (Q1, 2018)

701.8 m

Net income (Q1, 2018)

39.2 m

EBIT (Q1, 2018)

71.9 m

Market capitalization (23-May-2018)

5.2 b

Closing share price (23-May-2018)

81.4

Cash (31-Mar-2018)

129.9 m

EV

6.3 b
PRA Health Sciences's current market capitalization is $5.2 b.
Annual
USDFY, 2015FY, 2016

Revenue

1.6 b1.8 b

Revenue growth, %

12%

General and administrative expense

69.7 m269.9 m

Operating expense total

69.7 m269.9 m
Quarterly
USDQ1, 2016Q1, 2018

Revenue

430.2 m701.8 m

General and administrative expense

64 m91.7 m

Operating expense total

64 m91.7 m

Depreciation and amortization

27.3 m
Annual
USDFY, 2015FY, 2016

Cash

121.1 m144.6 m

Inventories

30.2 m35.4 m

Current Assets

573.8 m624.7 m

Goodwill

1 b972 m
Quarterly
USDQ1, 2016Q1, 2018

Cash

97.6 m129.9 m

Current Assets

559 m794.9 m

PP&E

147.4 m

Goodwill

1 b1.5 b
Annual
USDFY, 2015FY, 2016

Net Income

(39.9 m)68.2 m

Depreciation and Amortization

25.3 m69.5 m

Accounts Payable

(46.2 m)(1.5 m)

Cash From Operating Activities

35.9 m160 m
Quarterly
USDQ1, 2016Q1, 2018

Net Income

(16 m)39.2 m

Depreciation and Amortization

17 m27.3 m

Cash From Operating Activities

2.7 m34.6 m

Purchases of PP&E

(8.1 m)(13.8 m)
USDY, 2018

EV/EBIT

88 x

EV/CFO

183 x

Financial Leverage

3.5 x
Show all financial metrics
Report incorrect company information

PRA Health Sciences News and Updates

Clinical Trials Market Key Vendors (INC Research, inVentiv Health, PRA Health Sciences, Chiltern International, Charles River Laboratories, etc…) Analysis, Application, Significant Growth in Future & Regional Analysis – Forecast to 2022

ReportsWeb.com added “Global Clinical Trials Market Size Status and Forecast 2022” to its vast collection of research Database. The report classifies the global Clinical Trials Market in a precise manner to offer detailed insights into the aspects responsible for augmenting as well as restraining ma…
Report incorrect company information